Flomics is excited to announce a partnership with Lifebit in order to deploy an end-to-end cloud solution for COVID19 NGS data analysis. By combining Flomics’ expertise in NGS analysis with the flexibility and scalability of Lifebit’s CloudOS we aim to help worldwide hospitals, clinics and research laboratories in transforming raw data into interpretable clinical information. Without the need for computational infrastructures or bioinformatics expertise.
Access to more accurate data is key to manage this pandemic in an effective way. SARS-Cov-2 Next Generation Sequencing (NGS) experiments will help us understanding and predicting the clinical outcome of patients, detecting infection chains and managing the virus before new outbreaks appear. And this is just the beginning.
Get in touch with our team to learn how you can benefit from such a powerful alliance!
More info:
https://www.flomics.com/covid19/
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory